Pular para o conteúdo
Merck
  • Effects of omega-O-acylceramide structures and concentrations in healthy and diseased skin barrier lipid membrane models.

Effects of omega-O-acylceramide structures and concentrations in healthy and diseased skin barrier lipid membrane models.

Journal of lipid research (2019-12-21)
Lukáš Opálka, Andrej Kováčik, Petra Pullmannová, Jaroslav Maixner, Kateřina Vávrová
RESUMO

Ceramides (Cers) with ultralong (∼32-carbon) chains and ω-esterified linoleic acid, composing a subclass called omega-O-acylceramides (acylCers), are indispensable components of the skin barrier. Normal barriers typically contain acylCer concentrations of ∼10 mol%; diminished concentrations, along with altered or missing long periodicity lamellar phase (LPP), and increased permeability accompany an array of skin disorders, including atopic dermatitis, psoriasis, and ichthyoses. We developed model membranes to investigate the effects of the acylCer structure and concentration on skin lipid organization and permeability. The model membrane systems contained six to nine Cer subclasses as well as fatty acids, cholesterol, and cholesterol sulfate; acylCer content-namely, acylCers containing sphingosine (Cer EOS), dihydrosphingosine (Cer EOdS), and phytosphingosine (Cer EOP) ranged from zero to 30 mol%. Systems with normal physiologic concentrations of acylCer mixture mimicked the permeability and nanostructure of human skin lipids (with regard to LPP, chain order, and lateral packing). The models also showed that the sphingoid base in acylCer significantly affects the membrane architecture and permeability and that Cer EOP, notably, is a weaker barrier component than Cer EOS and Cer EOdS. Membranes with diminished or missing acylCers displayed some of the hallmarks of diseased skin lipid barriers (i.e., lack of LPP, less ordered lipids, less orthorhombic chain packing, and increased permeability). These results could inform the rational design of new and improved strategies for the barrier-targeted treatment of skin diseases.

MATERIAIS
Número do produto
Marca
Descrição do produto

Millipore
Solução forte de remoção de anticorpos ReBlot Plus, 10x
Avanti
C24 Ceramide (d18:1/24:0), Avanti Research - A Croda Brand
CellCrown inserts, 6 well plate inserts with 1.0 μm polycarbonate filter, sterile